このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
SMS Pharmaceuticals Limited 競合他社
価格と性能
| Historical stock prices | |
|---|---|
| Current Share Price | ₹215.21 |
| 52 Week High | ₹221.90 |
| 52 Week Low | ₹88.00 |
| Beta | 1.2 |
| 1 Month Change | 3.72% |
| 3 Month Change | 16.36% |
| 1 Year Change | 128.46% |
| 3 Year Change | 22.84% |
| 5 Year Change | 298.17% |
| Change since IPO | 499.05% |
最新ニュース
Recent updates
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?
Oct 08Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?
Sep 17SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 26SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Could Signal Some Risk
Aug 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Business Is Trailing The Market But Its Shares Aren't
Aug 08SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Looks Just Right
Jul 25株主還元
| SMSPHARMA | IN Pharmaceuticals | IN 市場 | |
|---|---|---|---|
| 7D | 3.0% | 0.5% | 2.4% |
| 1Y | 128.5% | 52.5% | 45.1% |
業界別リターン: SMSPHARMA過去 1 年間で52.5 % の収益を上げたIndian Pharmaceuticals業界を上回りました。
リターン対市場: SMSPHARMA過去 1 年間で45.1 % の収益を上げたIndian市場を上回りました。
価格変動
| SMSPHARMA volatility | |
|---|---|
| SMSPHARMA Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
安定した株価: SMSPHARMAの株価は過去 3 か月間にわたって変動しています。
時間の経過による変動: SMSPHARMAの 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1987 | 1,095 | Ramesh Potluri | www.smspharma.com |
エス・エム・エス・ファーマシューティカルズ社はインドで原薬と中間体を製造・販売している。抗潰瘍剤、抗真菌剤、抗偏頭痛剤、抗糖尿病剤、抗てんかん剤、抗精神病剤、抗炎症剤、抗真菌剤、抗ウイルス剤、抗凝固剤、抗レトロウイルス剤などを提供している。また、受託研究活動も行っている。製品の輸出も行っている。エス・エム・エス・ファーマシューティカルズ社は1987年に設立され、インドのハイデラバードに拠点を置く。
SMS Pharmaceuticals Limited 基礎のまとめ
| SMSPHARMA 基礎統計学 | |
|---|---|
| 時価総額 | ₹18.22b |
| 収益（TTM） | ₹498.26m |
| 売上高(TTM) | ₹7.09b |
36.6x
PER（株価収益率2.6x
P/SレシオSMSPHARMA は割高か？
公正価値と評価分析を参照収益と収入
| SMSPHARMA 損益計算書（TTM） | |
|---|---|
| 収益 | ₹7.09b |
| 売上原価 | ₹4.98b |
| 売上総利益 | ₹2.12b |
| その他の費用 | ₹1.62b |
| 収益 | ₹498.26m |
直近の収益報告
Mar 31, 2024
次回決算日
該当なし
| 一株当たり利益（EPS） | 5.89 |
| グロス・マージン | 29.83% |
| 純利益率 | 7.03% |
| 有利子負債／自己資本比率 | 52.2% |
SMSPHARMA の長期的なパフォーマンスは？
過去の実績と比較を見る